Response to letter entitled: Re: Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over design

Eur J Cancer. 2023 Sep:191:112980. doi: 10.1016/j.ejca.2023.112980. Epub 2023 Aug 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Child
  • Cross-Over Studies
  • Dexamethasone* / adverse effects
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Hydrocortisone* / therapeutic use
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
  • Randomized Controlled Trials as Topic

Substances

  • Dexamethasone
  • Hydrocortisone